You have no items in your shopping cart.
Paclitaxel (HY-B0015) for cancer research. Navicixizumab can be used in the research of ovarian, primary peritoneal, or fallopian tube cancer." inertia="description"> Paclitaxel (HY-B0015) for cancer research. Navicixizumab can be used in the resea, Navicixizumab, , , " inertia="keywords">
You have no items in your shopping cart.
Catalog Number | orb2703343 |
---|---|
Category | Antibodies |
Description | Navicixizumab (OMP-305B83) is a bispecific anti-VEGF and anti-DLL4 inhibitory antibody. Navicixizumab can combine with Paclitaxel.html" class="link-product" target="_blank"> Paclitaxel (HY-B0015) for cancer research. Navicixizumab can be used in the research of ovarian, primary peritoneal, or fallopian tube cancer. |
CAS Number | [1638338-43-8] |
Conjugation | Unconjugated |
Target | Navicixizumab |
Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
Note | For research use only |
Expiration Date | 12 months from date of receipt. |
ELISA, FA, FACS, Kinetics | |
Human | |
Monoclonal | |
Unconjugated |
ELISA, FC | |
Human, Monkey | |
Monoclonal | |
Unconjugated |